Private equity in cardiology raises overuse concerns
As private equity’s infiltration into cardiology expands, what does this mean for the cost and quality of care? More
As private equity’s infiltration into cardiology expands, what does this mean for the cost and quality of care? More
At the Lown Institute event on hospital racial inclusivity, health equity experts weighed in on hospital segregation and strategies for improving inclusivity. Watch the full event recording! More
Most hospitals say advancing health equity in their communities is a priority, and our latest report examines just how well they’re doing. More
CMS just announced AHEAD, a new model of care for states that provides an alternative to traditional fee-for-service payment. What does this model entail and how will it impact hospitals? More
The list of ten drugs for Medicare price negotiation has been published! What do we know about these Medicare "blockbusters"? And how are drugmakers taking the news? More
Arnold Ventures (AV) has recently supported the Lown Institute with grant funding for two projects, allowing the organization to significantly expand its research into the financial behavior of U.S. hospitals. More
Register now for our Racial Inclusivity launch on Sept. 19, 2023. More
Cancer screenings save lives, right? It's actually more complicated than that... More
As health equity has become a central focus for hospitals and other healthcare institutions, how could AI help – or hinder – these efforts? More
The clear connection between social factors and health has led to the adoption of health-related social needs screening in an attempt to address health concerns outside of clinic walls. How can we make sure these screeners and resulting referral services are effective? More
Allina Health owns 13 hospitals and more than 90 clinics in Minnesota and Wisconsin. Its nonprofit status enabled Allina to avoid roughly $266 million in state, local and federal taxes in 2020, according to the Lown Institute, a think tank that studies health care. More
If you want to see an epic battle between hospitals and pharma, look no further than the 340B drug discount program. Why is this program so controversial, and what do new studies show about its effectiveness? More
Unlike its predecessor drug aducanumab, lecanemab actually showed a statistically significant difference in slowing cognitive decline in its clinical trial. But can the drug improve patients’ quality of life? More
Noelle Serino, the Lown Institute's newest policy analyst, traces her commitment to public health back to one life-changing event... More
“The distinction between not-for-profit and for-profit — certainly in health care and certainly in relationship to hospitals — is negligible or nonexistent,” said Vikas Saini, president of the Lown Institute, a nonpartisan think tank that publishes data on hospital CEO pay and community benefit spending. “This, I think, is additional evidence of that.” More
Hospitals are an outlier among nonprofits when it comes to CEO pay, and hospitals in Los Angeles are no exception. Here's what one union is doing about it... More
Critical Access hospitals serve patients that would otherwise have limited access to healthcare. How do they perform on the Lown Index? Let's take a look... More
The latest list of "best hospitals" from US News and World Report is out... how do they perform when equity is factored in? More
On the podcast "Turn on the Lights," hosted by Kedar Mate and Don Berwick of the Institute for Healthcare Improvement, Lown Institute president Vikas Saini explains how overuse takes hold in medicine and how patients can protect themselves from the harms of unnecessary care. More
How do we reimagine what opportunity looks like for all…and who is accountable for doing that? Watch the recording and read a brief recap of the recent NY Federal Reserve event, Investing in Health and Well-Being More